Anchor Capital Advisors LLC decreased its holdings in shares of The Clorox Company (NYSE:CLX – Free Report) by 26.0% in the 1st quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 15,955 shares of the company’s stock after selling 5,620 shares during the quarter. Anchor Capital Advisors LLC’s holdings in Clorox were worth $2,443,000 at the end of the most recent reporting period.
Several other hedge funds have also added to or reduced their stakes in the business. Vanguard Group Inc. lifted its holdings in shares of Clorox by 0.3% during the third quarter. Vanguard Group Inc. now owns 15,341,234 shares of the company’s stock worth $2,010,622,000 after buying an additional 44,344 shares in the last quarter. Point72 Asset Management L.P. bought a new position in Clorox in the fourth quarter valued at about $144,844,000. Norges Bank bought a new position in Clorox in the fourth quarter valued at about $128,382,000. Parsifal Capital Management LP bought a new position in Clorox in the fourth quarter valued at about $128,245,000. Finally, Confluence Investment Management LLC bought a new stake in shares of Clorox during the first quarter worth about $135,630,000. Institutional investors and hedge funds own 78.53% of the company’s stock.
Analysts Set New Price Targets
CLX has been the topic of several research reports. Citigroup reduced their price target on Clorox from $150.00 to $145.00 and set a “neutral” rating on the stock in a report on Wednesday, July 10th. Argus raised Clorox to a “hold” rating in a research note on Tuesday, June 4th. BNP Paribas initiated coverage on Clorox in a research note on Monday, June 24th. They issued an “underperform” rating and a $130.00 price objective on the stock. Barclays cut their price objective on Clorox from $136.00 to $132.00 and set an “underweight” rating on the stock in a research note on Thursday, May 2nd. Finally, Evercore ISI dropped their price target on Clorox from $145.00 to $142.00 and set an “underperform” rating on the stock in a research note on Wednesday, May 1st. Five analysts have rated the stock with a sell rating and fourteen have issued a hold rating to the company. According to data from MarketBeat.com, the stock currently has a consensus rating of “Hold” and an average target price of $144.67.
Clorox Stock Performance
Shares of NYSE CLX traded down $1.84 during trading on Monday, reaching $134.56. 388,515 shares of the stock traded hands, compared to its average volume of 1,238,155. The Clorox Company has a 52-week low of $114.68 and a 52-week high of $169.14. The company has a debt-to-equity ratio of 9.73, a current ratio of 0.90 and a quick ratio of 0.53. The company has a 50-day moving average of $134.74 and a 200-day moving average of $143.21. The stock has a market capitalization of $16.71 billion, a P/E ratio of 69.85, a price-to-earnings-growth ratio of 2.02 and a beta of 0.39.
Clorox (NYSE:CLX – Get Free Report) last issued its quarterly earnings results on Tuesday, April 30th. The company reported $1.71 EPS for the quarter, beating analysts’ consensus estimates of $1.33 by $0.38. The firm had revenue of $1.81 billion for the quarter, compared to analysts’ expectations of $1.87 billion. Clorox had a return on equity of 302.49% and a net margin of 3.33%. The business’s revenue for the quarter was down 5.3% compared to the same quarter last year. During the same quarter in the prior year, the firm earned $1.51 EPS. Analysts forecast that The Clorox Company will post 5.91 EPS for the current fiscal year.
Clorox Company Profile
The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.
See Also
- Five stocks we like better than Clorox
- How Technical Indicators Can Help You Find Oversold Stocks
- Automaker’s Bold Move to an EV Future: Is It Time to Buy Stock?
- Investing In Automotive Stocks
- Massive Breakout: This ETF Signals Big Gains for Small-Cap Stocks
- ETF Screener: Uses and Step-by-Step Guide
- Major Gaming Stock to Watch: Why It’s a Safe Bet Now
Want to see what other hedge funds are holding CLX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for The Clorox Company (NYSE:CLX – Free Report).
Receive News & Ratings for Clorox Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Clorox and related companies with MarketBeat.com's FREE daily email newsletter.